(Q34056512)

30 July 2017

1 reference

title

Adverse cutaneous drug reactions in patients with human immunodeficiency virus-1 infection (English)

1 reference

30 July 2017

Heller HM

1

1 reference

30 July 2017

1 July 2000

1 reference

30 July 2017

Clinics in Dermatology

1 reference

30 July 2017

18

1 reference

30 July 2017

4

1 reference

30 July 2017

485-489

1 reference

Cutaneous disease and drug reactions in HIV infection

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Nail and mucocutaneous hyperpigmentation with azidothymidine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Nail pigmentation associated with zidovudine: a review and report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Time-course of toxicity of reactive sulfonamide metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

N-acetylcysteine treatment and the risk of toxic reactions to trimethoprim-sulphamethoxazole in primary Pneumocystis carinii prophylaxis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials G

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

A penile ulceration in a patient with the acquired immunodeficiency syndrome. Foscarnet-induced penile ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Foscarnet-induced penile ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

Foscarnet-induced penile ulcer in an uncircumcised patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2899%2900144-3

7 January 2021

10.1016/S0738-081X(99)00144-3

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11024316